Cargando…

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4

Detalles Bibliográficos
Autor principal: Sharma, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072472/
http://dx.doi.org/10.1186/2051-1426-2-S2-I6
_version_ 1782322966029139968
author Sharma, P
author_facet Sharma, P
author_sort Sharma, P
collection PubMed
description
format Online
Article
Text
id pubmed-4072472
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40724722014-07-02 S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4 Sharma, P J Immunother Cancer Invited Speaker Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072472/ http://dx.doi.org/10.1186/2051-1426-2-S2-I6 Text en Copyright © 2014 Sharma; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Invited Speaker Presentation
Sharma, P
S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
title S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
title_full S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
title_fullStr S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
title_full_unstemmed S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
title_short S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
title_sort s35. investigating the icos/icosl pathway as a target for combination therapy with anti-ctla-4
topic Invited Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072472/
http://dx.doi.org/10.1186/2051-1426-2-S2-I6
work_keys_str_mv AT sharmap s35investigatingtheicosicoslpathwayasatargetforcombinationtherapywithantictla4